At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NPCE NeuroPace Inc.
Trading 11-15 12:47:59 EST
8.48
-1.20
-12.40%
High9.83
Low8.34
Vol56.59K
Open9.77
D1 Closing9.68
Amplitude15.39%
Mkt Cap253.11M
Tradable Cap95.06M
Total Shares29.85M
T/O514.87K
T/O Rate0.50%
Tradable Shares11.21M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
NeuroPace Third Quarter 2024 Earnings: Beats Expectations
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.